Headache

Article	Citations
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	463
Erratum	80
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	72
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	70
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	68
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	67
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	62
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	59
Migraine and peripheral pain models show differential alterations in neuronal complexity	53
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	51
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	50
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	47
Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment	44
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	43
Post‐traumatic headache: An unmet medical need	42
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	40
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	37
Migraine screening in English and Spanish	34
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	32
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	31
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	29
Sex and gender: Opportunities to expand research and understanding within headache medicine	28
Prevalence of primary stabbing headache: A meta‐analysis	28
Patient preference for early onset of efficacy of preventive migraine treatments	28
A retrospective review of sex differences of white matter hyperintensities in brain MRI of patients with migraine	27

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study	27
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	26
Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study	26
Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐bl	26
Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis	25
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	25
Neuromodulation for primary headache disorders: Advantages and challenges	24
Patient headache questionnaires can improve headache diagnosis and treatment in children	24
The teaching of headache medicine in France: A questionnaire‐based study	23
Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code	23
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	23
Crystal‐clear days and unclear days in migraine: A population‐based study	22
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	22
Telehealth as a new care delivery model: The headache provider experience	22
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	22
Headache and acute cerebrovascular disease: How do we differentiate primary and secondary headache disorders in the emergency setting?	21
Issue Information	21
Protracted headache after COVID‐19: A case series of 31 patients from a tertiary headache center	20
Post‐vaccination headache reporting: Trends according to the Vaccine Adverse Events Reporting System	20
Issue Information	20
	20
Assessing blood pressure changes and hypertension‐related outcomes in patients with migraine treated with erenumab: A systematic review and meta‐analysis	20
Efficacy of a pediatric headache infusion center: A single‐center experience	20
Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial	19
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials	19
Alcohol as a trigger of migraine attacks in people with migraine. Results from a large prospective cohort study in English‐speaking countries	19
Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings	19
The 2024 Headache editorial board Conflict of Interest Declarations	19
Recurrent painful ophthalmoplegic neuropathy with headache and oculomotor palsy 18 years apart	19
OnabotulinumtoxinA as a promising treatment for primary trochlear headache: A retrospective case series	19
Evaluation of vascular risk in patients with migraine with and without aura treated with erenumab: Post hoc analysis of pooled long‐term clinical trial data	18
Prevalence, characteristics, and factors associated with caffeine‐withdrawal headache during the first day of Ramadan	18
Dystonia phenomenology and treatment response in migraine	18
The elephant in the room: How the underfunding of headache research stunts the field	18
Socioeconomic and geographic inequalities in headache disability in Brazil: The 2019 National Health Survey	18
Changes in cognitive appraisal in a randomized controlled trial of mindfulness‐based cognitive therapy for patients with migraine	18
Issue Information	17
Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale	17
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records	17
Neck pain associated with migraine does not necessarily reflect cervical musculoskeletal dysfunction	17
Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial	16
Challenges in the management of new daily persistent headache at a tertiary headache center—A retrospective real‐world evidence study	16
Arachnoiditis following epidural blood patch—An avoidable rare complication due to blind technique: A response	16
Red flags in headache care	16
	16
Development and pharmacological characterization of novel multi‐ calcitonin gene‐related peptide and pituitary adenylate cyclase‐activating peptide receptor antagonists	16
Afterimage duration differs for migraine with or without aura	16
Essential components of care in a multidisciplinary headache center: Perspectives from headache neurology specialists	16
	16
The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence	16

Plain Language Summary Publication: Investigating the causal and genetic relationship between migraine and Parkinson’s disease	16
Issue Information	16
Melatonin for migraine prevention in children and adolescents: A randomized, double‐blind, placebo‐controlled trial after single‐blind placebo lead‐in	15
Effect of galcanezumab in women with episodic migraine meeting criteria for menstrually related migraine: A post hoc analysis of EVOLVE‐1 and EVOLVE‐2	15
Different dosage regimens of erenumab for the treatment of migraine: A systematic review and meta‐analysis of the efficacy and safety of randomized controlled trials	15
The current state of headache medicine education in the United States and Canada: An observational, survey‐based study of neurology clerkship directors and curriculum deans	15
Clinical factors associated with day‐to‐day peak pain severity in individuals with chronic migraine: A cohort study using daily prospective diary data	15
Emergency department utilization among patients who receive outpatient specialty care for headache: A retrospective cohort study analysis	15
Prediction of individual trigeminal pain sensitivity from gray matter structure within the sensorimotor network	15
The usefulness of osmophobia for the diagnosis of migraine in children and adolescents	15
Effect of wildfire smoke on primary headache disorders remains unclear	14
	14
Burden of migraine in Brazil: A cross‐sectional real‐world study	14
Timing and durability of response to erenumab in patients with chronic migraine	14
A man with tongue pain: A case study	13
Secondary nummular headache: Are they more common than we thought?	13
Essential but often overlooked reporting elements for Headache manuscripts	13
American Headache Society 64th Annual Scientific Meeting June 9–12, 2022 Denver, Colorado	13
Long‐term effectiveness of eptinezumab in the treatment of patients with chronic migraine and medication‐overuse headache	13
Intracranial hypotension as a contributor to isolated cortical vein thrombosis	13
Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials	13
Decision‐making impairment under ambiguity but not under risk may underlie medication overuse in patients with chronic migraine	12
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	12
Plain Language Summary Publication: The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American headache society evidence assessment of parenteral	12
Headache attributed to idiopathic intracranial hypertension and persistent post‐idiopathic intracranial hypertension headache: A narrative review	12
Issue Information	12
Clinical characteristics and patient‐reported outcomes of chronic and episodic migraine patients at a US tertiary headache center: A retrospective observational study	12
Headache in transgender men using gender‐affirming hormone therapy: A case–control study	12
Are psychological interventions efficacious for adults with migraine? A systematic review and meta‐analysis	12
Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype	12
Arachnoid granulations in idiopathic intracranial hypertension: Do they have an influence?	12
Beyond aura: Understanding migraine as a cycling pan‐sensory threshold disease	12
Beyond movement: Headache in patients with functional movement disorders	12
Characterization of trigeminal C‐fiber reactivity through capsaicin‐induced release of calcitonin gene‐related peptide	12
Plasma calcitonin gene–related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion	12
Digital headache self‐management interventions for patients with a primary headache disorder: A systematic review of randomized controlled trials	12
Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial	12
	12
Time to reconsider the association between migraine and white matter hyperintensities?	12
The pathogenic role of calcitonin gene‐related peptide and predictors of new‐onset migraine and long‐term outcomes after transcatheter atrial septal defect closure	11
Glial activation in pain and emotional processing regions in the nitroglycerin mouse model of chronic migraine	11
Plain Language Summary Publication: Evaluating the use of paracetamol to prevent fasting headache during the first week of Ramadan: A randomized, open‐label, clinical trial	11
The link between reversible cerebral vasoconstriction syndrome and transient global amnesia	11
A randomized trial of ketorolac and metoclopramide for migraine in the emergency department	11
Clinical features, disease progression, and use of healthcare resources in a large sample of 866 patients from 24 headache centers: A real‐life perspective from the Italian chROnic migraiNe (IRON) pro	11
The impact of updates in headache quality measures on adherence to best practices in a neurology resident clinic: A quality improvement study	11
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing‐off of erenumab within monthly treatment cycle	11
Validity of self‐reported migraine in adolescents and children	11
Exploring the impact of acute SARS‐CoV‐2 infection on headache pattern in patients with migraine: A novel Bayesian analysis	11
Development and validation of a novel patient‐reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary	11
Blink reflex: A practical test to evaluate the trigeminal nerve injury following percutaneous balloon compression for the treatment of trigeminal neuralgia	11
Migraine and infertility, merging concepts in women's reproductive health: A narrative review	11
Visual hypersensitivity in patients treated with anti‐calcitonin gene–related peptide (receptor) monoclonal antibodies	11
Mechanisms of change in posttraumatic headache–related disability: A mediation model	10
Cluster Analysis of Migraine‐associated Symptoms (CAMS) in youth: A retrospective cross‐sectional multicenter study	10
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	10
	10
Migraine epidemiology in collegiate student‐athletes: Findings from the Concussion Assessment, Research, and Education (CARE) Consortium	10
Magnetoencephalography studies in migraine and headache disorders: A systematic review	10
Issue Information	10
Migraine in the context of chronic primary pain, chronic overlapping pain disorders, and functional somatic disorders: A narrative review	10
Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment	10
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	10
Counting the cost: How migraine shapes lives and economies	9
Patient headache questionnaires can improve headache diagnosis and treatment in children	9
Heavy metal and trace element alterations in patients during a migraine attack	9
Celebrating Headache's 2023 graduating class of Assistant Editors	9
Long‐term evolution of white and gray matter structural properties in migraine	9
	9
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	9
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	9
Continuous updating of individual headache forecasting models using Bayesian methods	9
Role of memantine in the prophylactic treatment of episodic migraine: A systematic review	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	9
The importance of patient and family perspectives of clinical decisions in pediatric headache	9
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	9
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	9
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study	9
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	9
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	9

Trainee highlights	8
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	8
Heightened migraine risk in patients with rheumatoid arthritis: A national retrospective cohort study	8
	8
Efficacy of an educational website on headaches in schoolchildren: A cluster‐randomized controlled trial	8
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	8
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	8
Identifying and predicting headache trajectories among those with acute post‐traumatic headache	8
	8
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	8
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	8
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	8
Symptomatic visual snow in acute ischemic stroke: A case series	8
Author Index	8
	8
Headache basic science prize	7
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	7
Multi‐region local field potential signatures and brain coherence alternations in response to nitroglycerin‐induced migraine attacks	7
Machine learning models and classification algorithms in the diagnosis of vestibular migraine: A systematic review and meta‐analysis	7
Baseline factors associated with post‐stenting intracranial pressure in patients with idiopathic intracranial hypertension with venous sinus stenosis	7
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	7
Learning headache triggers through experience: A laboratory study	7
Different characteristics of cortical spreading depression in the sleep and wake states	7
Nerve block as neuropathic pain treatment for the great auricular nerve neuropathy: A case report	7
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	7
Plain Language Summary Publication: Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
Diagnostic accuracy of an artificial intelligence online engine in migraine: A multi‐center study	7
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	7
Issue Information	7
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	7
Intranasal treatment of cluster headache: A response	7
A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study	7
Structural aberrations of the brain associated with migraine: A narrative review	7
Alterations in the structure and function of the brain in adolescents with new daily persistent headache: A pilot MRI study	7
Welcoming Headache's 2024 incoming class of Assistant Editors	7
Good News? Bad News? Idiopathic intracranial hypertension and migraine	7
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	7
Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study	7
Pain medication beliefs in individuals with headache	6
Effects of multiple‐dose administration of zavegepant nasal spray on the single‐dose pharmacokinetics of ethinyl estradiol‐levonorgestrel	6
Issue Information	6
A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache	6
Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomi	6
The complex relationship between alcohol and migraine	6
Changes in migraine characteristics over 30 days of Ramadan fasting: A prospective study	6
AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?	6
Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine	6
Lacosamide for refractory trigeminal neuralgia and other facial pain—Case report	6
New insight into the neural mechanisms of migraine in adolescents: Relationships with sleep	6
Altered brain functional connectivity in patients with tension‐type headache	6
	6
Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment	6
	6
Headache launches the publication of plain language summaries	6
Twenty twenty … two: Headache and COVID‐19	6
Trainee highlights	6
Advancing our commitment to our peer reviewers	6
A multicenter, randomized, double‐blind, placebo‐controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 1	6
	6
Headache Assistant Editors 2021–2022	6
Efficacy of galcanezumab in proline‐rich transmembrane protein 2 (PRRT2)‐associated familial hemiplegic migraine: A case series	6
Changes in gamma‐aminobutyric acid and glutamate/glutamine levels in the right thalamus of patients with episodic and chronic migraine: A proton magnetic resonance spectroscopy study	6
Real world evidence of changes in CGRP monoclonal antibody and onabotulinumtoxinA prescription practices at the start of the COVID‐19 pandemic: An observational, retro	6
Headache neuroimaging: A survey of current practice, barriers, and facilitators to optimal use	6
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative review	6
Sustained response of galcanezumab in migraine prevention: Patient‐level data from a post hoc analysis in patients with episodic or chronic migraine	6
Asking the right questions: The value of headache specialty care	6
Perceived stress and pain severity in individuals with chronic migraine: A longitudinal cohort study using daily prospective diary data	6
Blood serum levels of PACAP and migraine onset: A systematic review and meta‐analysis of observational studies	6
The impact of a digital platform on migraine patient‐centered outcome research. Evaluation of midolordecabeza.org, a headache website in Spanish	6
Epidemiology, investigation, management, and outcome of headache in emergency departments (HEAD study)—A multinational observational study	6
A rare case of lupus cerebritis presenting as ictal epileptic headache: A case report	6